MicroRNAs are biomarkers of oncogenic human papillomavirus infections

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4262-4267

  Wang, Xiaohong ^a   Wang, Hsu Kun ^b   Li, Yang ^a,c   Hafner, Markus ^d   Banerjee, Nilam Sanjib ^b   Tang, Shuang ^a,f   Briskin, Daniel ^d   Meyers, Craig ^e   Chow, Louise T ^b   Xie, Xing ^c   Tuschl, Thomas ^d   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d ROCKEFELLER UNIVERSITY   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

DNA tumor viruses; Noncoding RNAs; Oncogenes E6 and E7; Regulatory RNAs; Virol oncogenesis

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 16; MICRORNA 22; MICRORNA 25; MICRORNA 27A; MICRORNA 29A; MICRORNA 378; MICRORNA 92A; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; KERATINOCYTE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS ONCOGENE;

DNA TUMOR VIRUSES; NONCODING RNAS; ONCOGENES E6 AND E7; REGULATORY RNAS; VIROL ONCOGENESIS;

BASE SEQUENCE; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; DNA PRIMERS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENIC VIRUSES; PAPILLOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA; UTERINE CERVICAL NEOPLASMS;

EID: 84896528671     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401430111     Document Type: Article

References (60)

1. Moscicki AB, et al. (2012) Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 30(Suppl 5):F24-F33.
2. Chaturvedi AK, et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294-4301.
3. Muñoz N, et al.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527. (Pubitemid 36159887)
4. de Sanjose S, et al.; Retrospective International Survey and HPV Time Trends Study Group (2010) Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048-1056.
5. Meyers C, Frattini MG, Hudson JB, Laimins LA (1992) Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257(5072): 971-973.
6. Dollard SC, et al. (1992) Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. Genes Dev 6(7):1131-1142.
7. Wang HK, Duffy AA, Broker TR, Chow LT (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 23(2):181-194.
8. Massad LS, et al.; 2012 ASCCP Consensus Guidelines Conference (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 121(4):829-846.
9. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6):1129-1136. (Pubitemid 120035062)
10. Roman A, Munger K (2013) The papillomavirus E7 proteins. Virology 445(1-2): 138-168.
11. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136(2): 215-233.
12. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153(3):654-665.
13. Landgraf P, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7):1401-1414. (Pubitemid 46970709)
14. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92-105.
15. Lu J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834-838. (Pubitemid 40839735)
16. Mitchell PS, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518.
17. Calin GA, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17):1793-1801. (Pubitemid 41549891)
18. Wang X, et al. (2009) Oncogenic HPV infection interrupts the expression of tumorsuppressive miR-34a through viral oncoprotein E6. RNA 15(4):637-647.
19. Wang X, Meyers C, Guo M, Zheng ZM (2011) Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer 129(6):1362-1372.
20. Melar-New M, Laimins LA (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84(10):5212-5221.
21. Wang X, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3(7):e2557.
22. Li Y, et al. (2011) Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224(4):484-495.
23. Wang F, et al. (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5):2580-2588.
24. Xu J, et al. (2013) Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32(8):976-987.
25. Zheng ZM, Wang X (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 1809(11-12):668-677.
26. Kaczkowski B, Morevati M, Rossing M, Cilius F, Norrild B (2012) A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens. Open Virol J 6:216-231.
27. Suzuki HI, et al. (2009) Modulation of microRNA processing by p53. Nature 460(7254): 529-533.
28. Shi M, et al. (2012) Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. J Pathol 228(2): 148-157.
29. Kent OA, et al. (2010) Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 24(24):2754-2759.
30. Jackson SJ, et al. (2013) Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development 140(9):1882-1891.
31. Nissan X, et al. (2011) miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification. Dev Biol 356(2):506-515.
32. Lal A, et al. (2009) miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3′UTR microRNA recognition elements. Mol Cell 35(5):610-625.
33. Martinez I, et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27(18):2575-2582. (Pubitemid 351550884)
34. McKenna DJ, McDade SS, Patel D, McCance DJ (2010) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84(20): 10644-10652.
35. Gunasekharan V, Laimins LA (2013) Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol 87(10):6037-6043.
36. Biswas S, et al. (2010) Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 107(15):6976-6981.
37. Nakamura M, et al. (2009) Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 387(2):442-448.
38. Bodily JM, Mehta KP, Laimins LA (2011) Human papillomavirus E7 enhances hypoxiainducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res 71(3):1187-1195.
39. Xiong J, Du Q, Liang Z (2010) Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29(35):4980-4988.
40. Zheng YS, et al. (2012) MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 31(1):80-92.
41. Lee DY, Deng Z, Wang CH, Yang BB (2007) MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104(51):20350-20355.
42. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223(2):102-115.
43. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839-843. (Pubitemid 40839736)
44. Hua Y, et al. (2013) miRConnect 2.0: Identification of oncogenic, antagonistic miRNA families in three human cancers. BMC Genomics 14:179.
45. Brosh R, et al. (2008) p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol 4:229.
46. Poliseno L, et al. (2010) Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3(117):ra29.
47. Woods K, Thomson JM, Hammond SM (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282(4):2130-2134. (Pubitemid 47076737)
48. Sylvestre Y, et al. (2007) An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282(4):2135-2143. (Pubitemid 47076740)
49. Shai A, Brake T, Somoza C, Lambert PF (2007) The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 67(4):1626-1635. (Pubitemid 46383388)
50. Feng M, et al. (2011) Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 30(19):2242-2251.
51. Ofir M, Hacohen D, Ginsberg D (2011) MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 9(4):440-447.
52. Veldman T, Liu X, Yuan H, Schlegel R (2003) Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci USA 100(14):8211-8216. (Pubitemid 36842524)
53. Wang YW, Chang HS, Lin CH, Yu WC (2007) HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int J Biochem Cell Biol 39(2):402-412. (Pubitemid 44873096)
54. Chang TC, et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40(1):43-50.
55. Li X, et al. (2013) c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 288(25):18121-18133.
56. Zhang X, et al. (2012) Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell 22(4):506-523.
57. Zhang X, et al. (2012) Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene 31(24):3002-3008.
58. Bueno MJ, et al. (2010) Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol Cell Biol 30(12):2983-2995.
59. Westholm JO, Lai EC (2011) Mirtrons: MicroRNA biogenesis via splicing. Biochimie 93(11):1897-1904.
60. Melamed Z, et al. (2013) Alternative splicing regulates biogenesis of miRNAs located across exon-intron junctions. Mol Cell 50(6):869-881.